Fatal XXXX secondary to enoxaparin.

@entity1 @entity1187 @entity3126 @entity1661 @entity812 @entity1410 @entity158 @entity583 @entity551 @entity2120
An 83-year-old @entity1 was transferred to our cardiac intensive care unit with an acute non-Q-wave @entity583 and @entity3126 . Enoxaparin was one component of the treatment regimen used. Her hospital course was complicated by episodes of @entity551 , as well as by recurrent left hip and left thigh @entity158 . The defining event occurred when the @entity1 became acutely @entity551 and developed @entity1661 , peritoneal signs, intense @entity812 , and a 3.3 g/dl hemoglobin decrease. Abdominal computed tomography showed a 9 x 6 x 20 cm left retroperitoneal @entity1410 . The @entity1410 was spontaneous, secondary to enoxaparin use. The @entity1 died despite vigorous supportive care. @entity2120 is being increasingly used in @entity1 with @entity1187 . Review of the medical literature revealed that this is the first reported case of a @entity1 with an @entity1187 who died as a result of an @entity2120 -induced, @entity1410 . This article reviews important clinical signs and symptoms, identifies high-risk @entity1 populations, and discusses management strategies.
